Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up ‐regulating SIRT1

ConclusionOur findings demonstrated that in the AD mice, BDMC has antagonistic effect on AD. And an intermediate step in the antagonism effect is caused by SIRT1 upregulation, which leading to decreased oxidative stress. Based on these, we concluded that BDMC injection into the lateral ventricle can act against AD by upregulating SIRT1 to antioxidative stress.

Source: Brain and Behavior - May 21, 2020 Category: Neurology Authors: Yan Xu, Rong Hu, Duanqun He, Guijuan Zhou, Heng Wu, Chenlin Xu, Bing He, Lin Wu, Yilin Wang, Yunqian Chang, Rundong Ma, Ming Xie, Zijian Xiao Tags: ORIGINAL RESEARCH Source Type: research